Conference to address AI and post-Dobbs health

Pregnancy in the post-Dobbs era, AI in medical practice and changing privacy regulations are among the topics to be addressed this week at the 25th Annual Emerging Issues in Healthcare Law Conference in New Orleans.

Joe Sowell, senior vice president and chief development officer at HCA Healthcare, will take part in a fireside chat on April 5 at 8:30 a.m. CDT at the in-person only meeting.

The programs include:

“Dr. Robot Will See You Now: Balancing the Law with Human and Artificial Intelligence in Medical Practice” will explore how AI-enabled medical devices are moving from automation with human control to systems that learn for themselves. In the future tools are expected to be developed that can direct care, possibly in ways that exceed human capacity. A physician, device counsel and policymaker-led panel will discuss whether these autonomous tools should require informed consent and regulation. They also will discuss how they will affect professional standards of care, possible liability and whether physicians should be obligated to use such devices.

“The World of Emerging Therapies and Alternative Substances in Health Care” offers a panel of experts providing an overview of how alternative substances are being looked at as emerging therapies in health care delivery, including the rise in use of cannabis, psilocybin, ketamine and kratom. They will discuss the legal status of each alternative substance, along with how each is viewed by consumers and health care professionals as well as the existing conflicts between state and federal regulation and how it applies to the DEA, CMS, medical board and accreditation considerations.